Episode Details

Early-stage MedTech gets riskier when investors confuse a compelling story with a credible device. Stronger diligence starts by testing whether the science is real, whether clinicians would actually use the product, and whether the company has thought seriously about regulatory fit, reimbursement logic, and engineering durability.

That framework becomes even more important in neurotech, where public fascination can outrun the evidence base and where the difference between a breakthrough and a weak claim is often diligence quality.

Episode Breakdown

00:00 Opening

02:42 Science and engineering filters

07:55 Why neurotech still has open space

17:15 Cybersecurity as a hardening issue

24:20 How specialist funds operate

38:13 Final reflections

40:58 End

The Med Device Cyber Podcast is brought to you by Blue Goat Cyber, cybersecurity experts providing essential security solutions for the medical device industry. Learn more by visiting https://bluegoatcyber.com.

If you're interested in our services or partnering with us, schedule a Discovery Session: https://go.bluegoatcyber.com/meetings/blue-goat-cyber/discovery-session

Christian Espinosa is the CEO and founder of Blue Goat Cyber. Trevor Slattery is the Chief Operating Officer at Blue Goat Cyber.

Christian Espinosa on LinkedIn: https://www.linkedin.com/in/christianespinosa/

Trevor Slattery on LinkedIn: https://www.linkedin.com/in/trevor-slattery-34852b1a9

Blue Goat Cyber on LinkedIn: https://www.linkedin.com/company/blue-goat-cyber/

Blue Goat Cyber on Instagram: https://www.instagram.com/bluegoatcyber/

Blue Goat Cyber on Facebook: https://www.facebook.com/bluegoatcyber/

Blue Goat Cyber on YouTube: https://www.youtube.com/@BlueGoatCyber/?sub_confirmation=1